Name | CGK 733 |
---|---|
Supplier | Tocris Bioscience |
Catalog | 2344 |
Prices | $149.00, $629.00 |
Sizes | 10 mg, 50 mg |
Function Type | Inhibitor |
Cas Number | 905973-89-9 |
Chemical Name | α-Phenyl-N-[2,2,2-trichloro-1-[[[(4-fluoro-3-nitrophenyl)amino]thioxomethyl]amino]ethyl]benzeneacetamide |
Formula | C23H18Cl3FN4O3S |
Molecular Weight | 555.84 |
Purity | >98 % |
Description | Originally defined as a selective inhibitor of ATR and ATM kinases. Induces cell death in prematurely senescent breast cancer cells. Decreases p21 CIP1 levels in premature senescent MCF-7 and HCT-116 cells; also exhibits antiproliferative activity in a range of cancer cell lines. Blocks camptothecin-induced p53 phosphorylation and protects cells from camptothecin-induced apoptosis. |
Supplier Page | Shop |
Crescenzi E, Palumbo G, de Boer J, Brady HJ. Clin Cancer Res. 2008 Mar 15;14(6):1877-87.
Cruet-Hennequart S, Glynn MT, Murillo LS, Coyne S, Carty MP. DNA Repair (Amst). 2008 Apr 2;7(4):582-96.
Goldstein M, Roos WP, Kaina B. Toxicol Appl Pharmacol. 2008 May 15;229(1):20-32. doi:
Won J, Kim M, Kim N, Ahn JH, Lee WG, Kim SS, Chang KY, Yi YW. Nat Chem Biol. 2008 Jul;4(7):431.
Alao JP, Sunnerhagen P. Radiat Oncol. 2009 Nov 10;4:51.
Bhattacharya S, Ray RM, Johnson LR. Cell Signal. 2009 Apr;21(4):509-22.